Connection

AMOS GAIKWAD to Humans

This is a "connection" page, showing publications AMOS GAIKWAD has written about Humans.
Connection Strength

0.134
  1. Detection of lymphoid and myeloid lineages in infantile B-cell acute lymphoblastic leukemia with mixed-lineage leukemia rearrangement by use of flow cytometry and cytogenetic analysis. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S2-5.
    View in: PubMed
    Score: 0.013
  2. Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia. Int J Clin Exp Pathol. 2014; 7(9):6225-30.
    View in: PubMed
    Score: 0.013
  3. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia. Br J Haematol. 2009 Mar; 144(6):930-2.
    View in: PubMed
    Score: 0.009
  4. Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera. Exp Hematol. 2007 Nov; 35(11):1647-56.
    View in: PubMed
    Score: 0.008
  5. Imatinib effect on growth and signal transduction in polycythemia vera. Exp Hematol. 2007 Jun; 35(6):931-8.
    View in: PubMed
    Score: 0.008
  6. In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele. Exp Hematol. 2007 Apr; 35(4):587-95.
    View in: PubMed
    Score: 0.008
  7. Triterpenoid electrophiles (avicins) suppress heat shock protein-70 and x-linked inhibitor of apoptosis proteins in malignant cells by activation of ubiquitin machinery: implications for proapoptotic activity. Clin Cancer Res. 2005 Mar 01; 11(5):1953-62.
    View in: PubMed
    Score: 0.007
  8. Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression. Leuk Lymphoma. 2023 02; 64(2):462-467.
    View in: PubMed
    Score: 0.006
  9. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome. Haematologica. 2022 04 01; 107(4):887-898.
    View in: PubMed
    Score: 0.005
  10. Short NK- and Na?ve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):453-460.
    View in: PubMed
    Score: 0.005
  11. Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series. Leuk Lymphoma. 2020 12; 61(14):3515-3518.
    View in: PubMed
    Score: 0.005
  12. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Blood Adv. 2019 12 23; 3(24):4215-4227.
    View in: PubMed
    Score: 0.005
  13. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2019 10; 66(10):e27905.
    View in: PubMed
    Score: 0.005
  14. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatr Blood Cancer. 2019 08; 66(8):e27798.
    View in: PubMed
    Score: 0.004
  15. Improving diagnosis and treatment of acute childhood leukemia in Uganda: impact of flow cytometry. Blood Adv. 2018 11 30; 2(Suppl 1):21-23.
    View in: PubMed
    Score: 0.004
  16. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. Am J Transplant. 2018 09; 18(9):2238-2249.
    View in: PubMed
    Score: 0.004
  17. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma. J Pediatr Hematol Oncol. 2017 11; 39(8):e486-e488.
    View in: PubMed
    Score: 0.004
  18. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Mol Ther. 2016 09 29; 24(9):1615-26.
    View in: PubMed
    Score: 0.004
  19. Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor. Invest New Drugs. 2011 Oct; 29(5):818-26.
    View in: PubMed
    Score: 0.002
  20. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010 Apr 15; 184(8):4557-67.
    View in: PubMed
    Score: 0.002
  21. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation. Cancer Sci. 2008 Jun; 99(6):1265-73.
    View in: PubMed
    Score: 0.002
  22. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol. 2008 Nov; 128(11):2728-2735.
    View in: PubMed
    Score: 0.002
  23. Missense mutation of the last nucleotide of exon 1 (G->C) of beta globin gene not only leads to undetectable mutant peptide and transcript but also interferes with the expression of wild allele. Haematologica. 2007 Dec; 92(12):1715-6.
    View in: PubMed
    Score: 0.002
  24. A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase. Cell Death Differ. 2007 Nov; 14(11):1948-57.
    View in: PubMed
    Score: 0.002
  25. Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol. 2007 Jan; 35(1):32-8.
    View in: PubMed
    Score: 0.002
  26. A novel mutation of the cytochrome-b5 reductase gene in an Indian patient: the molecular basis of type I methemoglobinemia. Haematologica. 2006 Nov; 91(11):1542-5.
    View in: PubMed
    Score: 0.002
  27. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J Clin Invest. 2004 Jan; 113(1):65-73.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.